<SEC-DOCUMENT>0001628280-23-021025.txt : 20230606
<SEC-HEADER>0001628280-23-021025.hdr.sgml : 20230606
<ACCEPTANCE-DATETIME>20230606080839
ACCESSION NUMBER:		0001628280-23-021025
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230606
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20230606
DATE AS OF CHANGE:		20230606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zai Lab Ltd
		CENTRAL INDEX KEY:			0001704292
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38205
		FILM NUMBER:		23994938

	BUSINESS ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
		BUSINESS PHONE:		862161632588

	MAIL ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zlab-20230606.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:33ed529a-2c1f-4444-aedb-a795ba57e00b,g:a2cd7116-af88-49eb-8af0-e1c4b587d843,d:9515c2d5bb6e4284af873766cff4e251--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>zlab-20230606</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV80L2ZyYWc6MWE0YzBjYTVkYWU1NGVkMThiMzBjYTVlYTUxOGNhYmQvdGFibGU6YjMzMjlhODkzNzRhNGQzOGI3YWEyZTllYzVjYTdhNmEvdGFibGVyYW5nZTpiMzMyOWE4OTM3NGE0ZDM4YjdhYTJlOWVjNWNhN2E2YV8wLTEtMS0xLTU4MTEw_7aae56b2-7d39-4845-bdfa-89945fe3e6bf">false</ix:nonNumeric><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV80L2ZyYWc6MWE0YzBjYTVkYWU1NGVkMThiMzBjYTVlYTUxOGNhYmQvdGFibGU6YjMzMjlhODkzNzRhNGQzOGI3YWEyZTllYzVjYTdhNmEvdGFibGVyYW5nZTpiMzMyOWE4OTM3NGE0ZDM4YjdhYTJlOWVjNWNhN2E2YV8xLTEtMS0xLTU4MTEw_0c7c2fd8-28cb-4afb-9024-7841b2259332">0001704292</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="zlab-20230606.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-06</xbrli:startDate><xbrli:endDate>2023-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-06</xbrli:startDate><xbrli:endDate>2023-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-06</xbrli:startDate><xbrli:endDate>2023-06-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9515c2d5bb6e4284af873766cff4e251_1"></div><div style="min-height:9.72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:80%">FORM&#160;<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA1_87f7fa7e-529f-4756-8797-800051bdd6e7">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:90%">CURRENT REPORT</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:90%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:90%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8yNzQ_f591d6cf-dec9-48ea-9a86-21de2325ee84">June 6, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:80%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA3_6046de8d-5433-45f5-a980-d315da838e30">ZAI LAB LIMITED</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:80%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">________________________</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTAtMS0xLTU4MTEw_7fd98739-9bde-48ab-8789-081a2f9930aa">Cayman Islands</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTEtMS0xLTU4MTEw_1585dd39-3c93-48a1-bf8a-ac92e05e75b5">001-38205</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTItMS0xLTU4MTEw_4bcfc59c-e473-4709-8df4-713689fbde3f">98-1144595</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfNQ_d8a290d1-c4d1-4eb8-a6e5-d11d1181982a">4560 Jinke Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfOA_673a6c74-af97-419b-82b1-33b34db36474">Bldg. 1, Fourth Floor, Pudong</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfMTE_ed8e8dab-5814-449a-bfb7-6390b679cfc6">Shanghai</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfMTU_b76fec1e-01f7-4355-9fdf-40e4150562b5">China</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTEtMS0xLTU4MTEw_35cc901b-9a69-4c7a-ba27-df99d5cbfc28">201210</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">314 Main Street<br/>4th Floor, Suite 100<br/>Cambridge, MA, USA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">02142</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA4_07d9ae4e-057d-4157-a7b8-bb1762d56b72">86 21</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjAz_9b169139-78cb-4ff2-884a-cbf445da0e2d">6163 2588</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:107%">+1 857 706 2604</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:90%">Not Applicable</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________________</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:0.1%"></td><td style="width:2.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M18wLTAtMS0xLTU4MTEw_c8beacb1-fbdc-4548-bec2-0de820c8bf6e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M18yLTAtMS0xLTU4MTEw_253e6644-daa1-4665-b5e4-eb13da9a9819">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M180LTAtMS0xLTU4MTEw_631199fb-9f39-4acf-8cfb-123879757600">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M182LTAtMS0xLTU4MTEw_eea57229-57fe-4a7d-8df4-f7185095b3c7">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:1.0%"></td><td style="width:31.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTAtMS0xLTU4MTEw_2ffe3d66-2203-4517-8a9f-2005b51a2660">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTItMS0xLTU4MTEw_c72cb60a-9d09-444b-88db-0825dea37cae">ZLAB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTQtMS0xLTU4MTEw_774cfbfc-7c76-4885-ae28-ac065415770b">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8yLTAtMS0xLTU4MTEw_5e6e7d91-c1f0-4661-8cd0-a31335057e41">Ordinary Shares, par value $0.000006 per share*</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8yLTItMS0xLTU4MTEw_ee5788a5-175c-44d7-ba61-1f47834a9ea4">9688</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The Stock Exchange of Hong Kong Limited</span></td></tr></table></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:22.5pt">Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not registered or listed for trading in the United States but are listed for trading on The Stock Exchange of Hong Kong Limited</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company&#160;<ix:nonNumeric contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA0_23edabd0-de73-4a8c-bf23-48142e855e50">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:9.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9515c2d5bb6e4284af873766cff4e251_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item&#160;8.01 Other Events. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2023, Zai Lab Limited (the &#8220;Company&#8221;), together with its partner NovoCure Limited (&#8220;Novocure&#8221;), issued a press release announcing that Novocure&#8217;s LUNAR Phase 3 clinical trial, evaluating the safety and efficacy of Tumor Treating Fields together with standard therapies for patients with metastatic non-small cell lung cancer who progressed during or after platinum-based therapies, demonstrated a statistically significant and clinically meaningful extension in overall survival. The Company has an exclusive license from Novocure to develop and commercialize Tumor Treating Fields in mainland China, Hong Kong, Macau, and Taiwan.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div id="i9515c2d5bb6e4284af873766cff4e251_13"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm">Press Release issued by Zai Lab Limited on</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm">June</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm">&#160;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023-06x06xlunarclinicalt.htm">, 2023.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page of this Current Report on Form&#160;8-K&#160;is formatted in Inline XBRL</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9515c2d5bb6e4284af873766cff4e251_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ZAI LAB LIMITED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ F. Ty Edmondson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F. Ty Edmondson</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: June 6, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>a2023-06x06xlunarclinicalt.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iec4f20cb1c824b66aaf9f73d8de6a550_42"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><img alt="zailablogoa.jpg" src="zailablogoa.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div><font><br></font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies</font></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="padding-left:7.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities</font></div><div style="padding-left:24.95pt"><font><br></font></div><div style="padding-left:7.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival</font></div><div style="padding-left:24.95pt"><font><br></font></div><div style="padding-left:7.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in metastatic non-small cell lung cancer post-platinum therapy</font></div><div style="padding-left:24.95pt"><font><br></font></div><div style="padding-left:7.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Data from the LUNAR trial to be presented today during the 2023 ASCO Annual Meeting</font></div><div style="padding-left:7.05pt"><font><br></font></div><div style="padding-left:7.05pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SHANGHAI, CAMBRIDGE, Mass., and ROOT, Switzerland</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; Zai Lab Limited (NASDAQ&#58; ZLAB&#59; HKEX&#58; 9688) and Novocure (NASDAQ&#58; NVCR) today are presenting positive results from the phase 3 LUNAR clinical trial evaluating the use of Tumor Treating Fields (TTFields) therapy together with standard therapies for the treatment of non-small cell lung cancer (NSCLC) at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. The LUNAR trial met its primary endpoint with a statistically significant and clinically meaningful 3-month improvement in median overall survival (OS) when TTFields therapy was added to standard therapies (HR&#58; 0.74, P&#61;0.035).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients randomized to receive TTFields therapy together with standard therapies (n&#61;137) demonstrated median OS of 13.2 months compared to 9.9 months in patients treated with standard therapies alone (n&#61;139). A profound OS benefit from TTFields therapy was demonstrated in the immune checkpoint inhibitor (ICI) subgroup. Patients randomized to receive TTFields therapy and physician&#8217;s choice ICI (n&#61;66) demonstrated a median OS of 18.5 months versus a median OS of 10.8 months in patients treated with ICIs alone (n&#61;68&#59; HR&#61;0.63&#59; P&#61;0.03). Patients randomized to receive TTFields therapy and docetaxel (n&#61;71) had a positive survival trend with a median OS of 11.1 months vs 8.7 months in patients treated with docetaxel alone (n&#61;71). TTFields therapy was well-tolerated with no added systemic toxicities and few grade 3 (no grade 4 or 5) device-related adverse events.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;The results of the LUNAR study are highly encouraging,&#8221; said primary investigator Ticiana Leal, M.D., a researcher and medical oncologist at Winship Cancer Institute of Emory University and associate professor and director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta. &#8220;The LUNAR trial is the first study in more than seven years to show a significant improvement in overall survival in metastatic non-small cell lung cancer post-platinum chemotherapy. I am heartened by this progress and the potential of this innovative therapy to help many metastatic lung cancer patients in need of new treatment choices following platinum therapy, without added systemic toxicity.&#8221;&#160;&#160; </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;The significant improvement in overall survival as demonstrated in the LUNAR study is groundbreaking. Lung cancer is the leading cause of cancer-related death in China, and non-small cell lung cancer is the most common form of this disease. The prognosis is often very poor for patients who progress after treatment with a platinum-containing regimen in the front-line setting,&#8221; said professor Li Zhang, M.D., Sun Yat-sen University Cancer Center. &#8220;I am very excited that this novel, non-invasive device can bring significant benefit to patients living with metastatic NSCLC in China.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baseline characteristics were well balanced between cohorts&#58; median age was 64 years (range, 22-86)&#59; 65% male&#59; 96% of patients had an ECOG performance status of 0-1. Patients were enrolled at sites in North America (30%), Western Europe (30%), Eastern Europe (30%) and East Asia (9%). One-year survival rates for patients treated with TTFields therapy together with standard therapies was 53% versus 42% for patients treated with standard therapies alone (P&#61;0.04). A landmark three-year survival analysis for patients treated with TTFields therapy together with standard therapies demonstrated a nearly threefold improvement, extending to 18% versus 7% for patients treated with standard therapies alone (P&#61;0.015). Median progression-free survival (PFS) for patients treated with TTFields therapy together with standard therapies was 4.8 months versus 4.1 months in patients treated with standard therapies alone. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Of patients randomized, 89% had one prior line of systemic therapy and 31% of patients randomized had been treated with an ICI (58% of patients randomized to the docetaxel cohort and 2% of patients randomized to the ICI cohort). ICIs were approved for first-line NSCLC in 2017 during the conduct of the LUNAR study, and PD-L1 expression data were collected thereafter in geographic regions where ICIs had been adopted. Tumor Proportion Scores were available for 151 patients globally (55%) and were well balanced across the cohorts. In all patients treated with ICI and with measured Tumor Proportion Scores, 63% had PD-L1 expression &#62;1%, which is in-line with real-world data. PD-L1 expression data were collected from 83% of patients (69 of 83 patients) enrolled at U.S. sites and were well balanced across the four cohorts. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PD-L1 Status&#58;</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.086%"><tr><td style="width:1.0%"></td><td style="width:13.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.169%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PD-L1 Expression</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TTFields + SOC (n&#61;137)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SOC<br>(n&#61;139)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TTFields + ICI (n&#61;66)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ICI<br>(n&#61;68)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TTFields + DTX (n&#61;71)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DTX<br>(n&#61;71)</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#60;1%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-49%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#62;50%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</font></td></tr></table></div><div style="margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DTX &#61; docetaxel&#59; ICI &#61; immune checkpoint inhibitor&#59; SOC &#61; standard of care</font></div><div style="margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novocure has submitted the LUNAR clinical trial results for publication in a leading, peer-reviewed medical journal. The LUNAR clinical trial data are expected to serve as the basis for a Premarket Approval (PMA) submission to the U.S. Food and Drug Administration in the second half of 2023. Zai Lab contributed to the China portion of the LUNAR study and plans to submit a Marketing Authorization Application (MAA) to China&#8217;s National Medical Products Administration (NMPA) following Novocure&#8217;s submission to the FDA. </font></div><div style="margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;I would like to thank our patients, their families and caregivers for participating in the LUNAR trial,&#8221; said William Doyle, Novocure&#8217;s Executive Chairman. &#8220;I would also like to thank Dr. Leal and all of our investigators for their expertise and dedication to advancing the care of patients. The LUNAR trial results represent tremendous progress for the treatment of metastatic non-small cell lung cancer, and the LUNAR trial demonstrates the broad and versatile potential of TTFields therapy in improving the survival of cancer patients with high unmet needs. We are energized by the LUNAR results and are moving forward quickly to make TTFields therapy available to patients with metastatic non-small cell lung cancer.&#8221;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Each year in China, approximately 740,000 patients are newly diagnosed with non-small cell lung cancer, and most patients are diagnosed at an advanced stage. The LUNAR trial results demonstrate the potential of TTFields to meaningfully extend survival for many patients with advanced, platinum-resistant NSCLC,&#8221; said Dr. Samantha Du, Founder, Chairperson, and Chief Executive Officer of Zai Lab. &#8220;We are pleased to have been able to contribute to the LUNAR study, and we look forward to working with Novocure to bring TTFields to patients with metastatic NSCLC as soon as possible.&#8221;   </font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novocure is dedicated to advancing TTFields therapy for patients with solid tumors. The LUNAR clinical trial is the first of four phase 3 clinical trials expected to readout by the end of 2024 studying the use of TTFields therapy for the treatment of solid tumors of the brain, torso and abdomen. Based on the strength of the LUNAR data, Novocure intends to launch additional phase 3 trials evaluating TTFields therapy in earlier lines of treatment and together with ICIs and other standards of care. </font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to LUNAR, Zai Lab participated in two of Novocure&#8217;s ongoing phase 3 clinical trials - the METIS trial (brain metastases resulting from NSCLC) and the PANOVA-3 trial (pancreatic cancer). Zai Lab also conducted the EF-31 phase 2 trial, in collaboration with Novocure, studying the use of TTFields in the treatment of gastric cancer in China.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investor Event details</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novocure will host an investor event at 2 p.m. CDT on Tuesday, June 6, 2023.&#160;The event will include a presentation and discussion of the LUNAR clinical trial data, featuring leading thoracic oncologists, investigators, and Novocure leadership.&#160;A live webcast of the event will be available on the investor relations page of </font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.novocure.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. For more information or to request in-person attendance, please contact Novocure investor relations (</font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">investorinfo&#64;novocure.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About LUNAR</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LUNAR is a phase 3 trial testing the safety and effectiveness of TTFields therapy when used together with ICI or docetaxel (experimental arm) versus ICI or docetaxel alone (control arm) for patients with metastatic NSCLC who progressed during or after platinum-based therapy. The primary endpoint is superior overall survival of patients treated with TTFields therapy plus ICI or docetaxel versus ICI or docetaxel alone. The powered secondary endpoints are superior overall survival of patients treated with TTFields therapy plus ICI versus ICI cohort and superior overall survival of patients treated with TTFields therapy plus docetaxel versus docetaxel alone. TTFields therapy is intended principally for use with other concomitant standard of care treatments, and LUNAR was designed to generate data that contemplates multiple outcomes, all of which Novocure believes will be clinically meaningful.</font></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About NSCLC in China</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lung cancer is the most commonly diagnosed cancer type and the leading cause of cancer death in China. There were approximately 871,000 new cases and 767,000 deaths of lung cancer in China in 2022, respectively.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> NSCLC accounts for approximately 85% of lung cancer, and approximately 70% of NSCLC is locally advanced or metastatic at initial diagnosis. Similar to the global clinical practice, physicians use different combinations of surgery, radiation and pharmacological therapies </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to treat NSCLC, depending on the stage of the disease.&#160;Surgery, which may be curative in a subset of patients, is usually used in early stages of the disease.&#160;Since 1991, radiation with a combination of platinum-based chemotherapy drugs has been the first-line standard of care for locally advanced or metastatic NSCLC.&#160;Certain immune checkpoint inhibitors have been approved for the first-line treatment of NSCLC and the standard of care in this setting appears to be evolving rapidly.&#160;The standard of care for second-line treatment is also evolving and may include platinum-based chemotherapy for patients who received immune checkpoint inhibitors as their first-line regimen, pemetrexed, docetaxel or immune checkpoint inhibitors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Source&#58; (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changfa Xia, et al. Cancer statistics in China and United States, 2022&#58; profiles, trends, and determinants.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About Novocure</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure&#8217;s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headquartered in Root, Switzerland and with a growing global footprint, Novocure has regional operating centers in Portsmouth, New Hampshire and Tokyo, as well as a research center in Haifa, Israel. For additional information about the company, please visit Novocure.com and follow &#64;Novocure on LinkedIn and Twitter.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Novocure Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure&#8217;s current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, clinical trial progress, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, coverage, collections from third-party payers and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe&#8221; or other words and terms of similar meaning. Novocure&#8217;s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, environmental, regulatory and political conditions as well as issues arising from the COVID-19 pandemic and other more specific risks and uncertainties facing Novocure such as those set forth in its Annual Report on Form 10-K filed on February 23, 2023, and subsequent filings with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Novocure does not intend to update publicly any forward-looking statement, except as required by law. Any forward-looking statements herein speak only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this discussion.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investors&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ingrid Goldberg</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">investorinfo&#64;novocure.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610-723-7427</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leigh Labrie</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">media&#64;novocure.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610-723-7428</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About Zai Lab</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (NASDAQ&#58; ZLAB&#59; HKEX&#58; 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at </font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">www.twitter.com&#47;ZaiLab_Global</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Zai Lab Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This press release contains forward-looking statements about future expectations, plans, and prospects, including, without limitation, statements relating to Tumor Treating Fields, the LUNAR study, and the potential treatment of patients with non-small cell lung cancer. All statements, other than statements of historical fact, included in this press release are forward-looking statements, and can be identified by words such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees or assurances of future performance. Forward-looking statements are based on our expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. We may not actually </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">achieve the plans, carry out the intentions, or meet the expectations or projections disclosed in our forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors, including but not limited to (1) our ability to successfully commercialize and generate revenue from our approved products, (2) our ability to obtain funding for our operations and business initiatives, (3) the results of our clinical and pre-clinical development of our product candidates, (4) the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of our product candidates, (5) the effects of the novel coronavirus (COVID-19) pandemic on our business and results of operations, (6) risks related to doing business in China, and (7) other factors identified in our most recent annual and quarterly reports and in other reports we have filed with the U.S. Securities and Exchange Commission (SEC). We anticipate that subsequent events and developments will cause our expectations and assumptions to change, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our SEC filings can be found on our website at www.zailaboratory.com and on the SEC&#8217;s website at www.sec.gov.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For more information, please contact&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investor Relations&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chiou&#160;&#47;&#160;Lina Zhang<br>+1 (917) 886-6929 &#47; +86 136 8257 6943<br>christine.chiou1&#64;zailaboratory.com&#160;&#47;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">lina.zhang&#64;zailaboratory.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Shaun Maccoun &#47; Xiaoyu Chen<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">+1 (415) 317-7255  &#47; +86</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> 185 0015 5011<br>shaun.maccoun&#64;zailaboratory.com&#160;&#47;&#160;xiaoyu.chen&#64;zailaboratory.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab Limited</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>zlab-20230606.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33ed529a-2c1f-4444-aedb-a795ba57e00b,g:a2cd7116-af88-49eb-8af0-e1c4b587d843-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zlab="http://zailab.com/20230606" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://zailab.com/20230606">
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20230606_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20230606_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20230606_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://zailab.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>zlab-20230606_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33ed529a-2c1f-4444-aedb-a795ba57e00b,g:a2cd7116-af88-49eb-8af0-e1c4b587d843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://zailab.com/role/Cover" xlink:type="simple" xlink:href="zlab-20230606.xsd#Cover"/>
  <link:definitionLink xlink:role="http://zailab.com/role/Cover" xlink:type="extended" id="i37081e6020b049578fc27f37890f5073_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_20d5ad39-d648-4178-9735-491a7b57e3e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_DocumentType_20d5ad39-d648-4178-9735-491a7b57e3e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1fafba7e-503b-478c-8b27-cb4126233a8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_DocumentPeriodEndDate_1fafba7e-503b-478c-8b27-cb4126233a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9e5cb420-e324-4249-a944-09379731e913" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityRegistrantName_9e5cb420-e324-4249-a944-09379731e913" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_92a85ea4-b6e8-4b86-b88a-aa5d9152e1e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityIncorporationStateCountryCode_92a85ea4-b6e8-4b86-b88a-aa5d9152e1e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5214084b-1345-41ef-b71b-f43dff820515" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityFileNumber_5214084b-1345-41ef-b71b-f43dff820515" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ca233508-b553-4c56-ad72-7cb80e45f25d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityTaxIdentificationNumber_ca233508-b553-4c56-ad72-7cb80e45f25d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d3fd22cb-bfd6-47b3-a43b-e76613a186e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressAddressLine1_d3fd22cb-bfd6-47b3-a43b-e76613a186e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_3d802944-807a-4bc5-845b-e7441ccfa78f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressAddressLine2_3d802944-807a-4bc5-845b-e7441ccfa78f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_86cb73ef-339a-48f6-b5d8-363c089ebcce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressCityOrTown_86cb73ef-339a-48f6-b5d8-363c089ebcce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_5e20484d-374b-48f9-b096-63d5a5c6f647" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressCountry_5e20484d-374b-48f9-b096-63d5a5c6f647" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_65af35c8-f8ac-494d-afcd-9709ddbe1566" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressPostalZipCode_65af35c8-f8ac-494d-afcd-9709ddbe1566" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ec7a2973-aedd-419c-973e-92288de44695" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_CityAreaCode_ec7a2973-aedd-419c-973e-92288de44695" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6d837b84-9d33-4d22-93bb-beeff9dfc976" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_LocalPhoneNumber_6d837b84-9d33-4d22-93bb-beeff9dfc976" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b1bef93c-60c3-47d7-a2ec-c874b50a2f48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_WrittenCommunications_b1bef93c-60c3-47d7-a2ec-c874b50a2f48" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a45a38cb-01ca-48f2-a77d-3665fd895a89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_SolicitingMaterial_a45a38cb-01ca-48f2-a77d-3665fd895a89" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_777862d7-a15b-40e2-aa9c-effe11f747f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_PreCommencementTenderOffer_777862d7-a15b-40e2-aa9c-effe11f747f5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e2941cce-479e-4014-91c5-b2dc3896240f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e2941cce-479e-4014-91c5-b2dc3896240f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_856e1890-2583-42e0-bbb6-92334808647c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_Security12bTitle_856e1890-2583-42e0-bbb6-92334808647c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_718e1a4a-6d7c-4bd5-b2ab-8d3e9bc0aa7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_TradingSymbol_718e1a4a-6d7c-4bd5-b2ab-8d3e9bc0aa7f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9c49ff29-666c-47fb-9189-b9889bdbb9f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_SecurityExchangeName_9c49ff29-666c-47fb-9189-b9889bdbb9f5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_93ef486b-bbf6-4805-a077-43adcf85f0ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityEmergingGrowthCompany_93ef486b-bbf6-4805-a077-43adcf85f0ff" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b520307f-5330-4b9a-bb96-b3e5048e1f05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_AmendmentFlag_b520307f-5330-4b9a-bb96-b3e5048e1f05" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_12336222-1449-48b3-91ba-1ede111f08c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityCentralIndexKey_12336222-1449-48b3-91ba-1ede111f08c8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fafc1259-3fab-4b92-bfed-bb47beb183bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:to="loc_us-gaap_ClassOfStockDomain_fafc1259-3fab-4b92-bfed-bb47beb183bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:to="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember_ca7a8e28-5c05-408f-8449-214b983db253" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AdrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:to="loc_dei_AdrMember_ca7a8e28-5c05-408f-8449-214b983db253" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91bf61dd-bd5f-49bb-8da3-d2461bd643c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:to="loc_us-gaap_CommonStockMember_91bf61dd-bd5f-49bb-8da3-d2461bd643c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>zlab-20230606_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33ed529a-2c1f-4444-aedb-a795ba57e00b,g:a2cd7116-af88-49eb-8af0-e1c4b587d843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_bf4987c9-e5e6-48ac-a41f-36021431d8af_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_b45265af-1741-460d-8232-8b8970cd7ece_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ca267d29-344c-4926-99b1-f5980593b364_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fa79cc76-8d5d-42a4-b5df-9d6d41fc63ea_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3eefc4aa-736f-48e1-95f8-88a0c99ccc37_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_2201b9d2-fb2d-46b9-b42a-59ba744c267b_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_27936adc-d042-4d7d-a961-23e8151a7445_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_058f7711-226f-4a57-90b1-168f13cd6c10_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_3a57bb9a-f4b9-4c16-9dba-8d4f1a6966a0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_53d8c8b1-f833-4c01-8c9b-458918a9218a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_789112ce-f9a1-422c-ba90-7b2830f49f40_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AdrMember_5c0fdf4f-9502-4746-bfdd-9bcc2e979ddb_terseLabel_en-US" xlink:label="lab_dei_AdrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADR</link:label>
    <link:label id="lab_dei_AdrMember_label_en-US" xlink:label="lab_dei_AdrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AdrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AdrMember" xlink:to="lab_dei_AdrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9f6c8f68-50ff-496a-a784-7f4d11e626a5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fc290df5-1e55-49ba-bdb0-b8eaf19ac986_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ba9162bd-040a-4a69-97a2-4275125a1808_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ad1c4b91-a4c8-4b4f-99b8-39d838bf52a4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9ed30df4-e813-4198-8424-d59f31efafd2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_00d8a55f-33d5-4603-8e70-2814a4cf22f5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d789e75c-a68c-489c-9f91-c261656a9ed1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ffed1d1b-4a0b-455b-92dd-8995276d34dc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5280d269-61d7-4301-84fe-c4a618e9ba8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_14173f12-589c-4a2c-bb78-e9686f3b07c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_13de81e2-abef-45ed-9ab4-306d1236673b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_857ac032-a8be-4fe3-ad83-bc1f7141b309_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b9c0a87a-a97d-4a3e-9f2e-b13cf2856653_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f3498a91-3775-4520-b91f-afec9fafaee9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_26213b2f-df54-4b19-aae6-d25d1ae30835_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_95740fb7-d4c5-464c-9d14-2f230cd1aee9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ff2780b9-9491-46ea-bca0-0f93cb524308_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>zlab-20230606_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33ed529a-2c1f-4444-aedb-a795ba57e00b,g:a2cd7116-af88-49eb-8af0-e1c4b587d843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://zailab.com/role/Cover" xlink:type="simple" xlink:href="zlab-20230606.xsd#Cover"/>
  <link:presentationLink xlink:role="http://zailab.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_db416be6-7459-4450-88cc-dd42f60336f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_db416be6-7459-4450-88cc-dd42f60336f3" xlink:to="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fafc1259-3fab-4b92-bfed-bb47beb183bf" xlink:to="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember_ca7a8e28-5c05-408f-8449-214b983db253" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AdrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:to="loc_dei_AdrMember_ca7a8e28-5c05-408f-8449-214b983db253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91bf61dd-bd5f-49bb-8da3-d2461bd643c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bdf3f23f-242b-48e2-baf9-52ff241cb3be" xlink:to="loc_us-gaap_CommonStockMember_91bf61dd-bd5f-49bb-8da3-d2461bd643c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_501799db-d982-44b4-bec1-9c836bdc8b2e" xlink:to="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_20d5ad39-d648-4178-9735-491a7b57e3e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_DocumentType_20d5ad39-d648-4178-9735-491a7b57e3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1fafba7e-503b-478c-8b27-cb4126233a8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_DocumentPeriodEndDate_1fafba7e-503b-478c-8b27-cb4126233a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9e5cb420-e324-4249-a944-09379731e913" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityRegistrantName_9e5cb420-e324-4249-a944-09379731e913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_92a85ea4-b6e8-4b86-b88a-aa5d9152e1e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityIncorporationStateCountryCode_92a85ea4-b6e8-4b86-b88a-aa5d9152e1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5214084b-1345-41ef-b71b-f43dff820515" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityFileNumber_5214084b-1345-41ef-b71b-f43dff820515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ca233508-b553-4c56-ad72-7cb80e45f25d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityTaxIdentificationNumber_ca233508-b553-4c56-ad72-7cb80e45f25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d3fd22cb-bfd6-47b3-a43b-e76613a186e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressAddressLine1_d3fd22cb-bfd6-47b3-a43b-e76613a186e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_3d802944-807a-4bc5-845b-e7441ccfa78f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressAddressLine2_3d802944-807a-4bc5-845b-e7441ccfa78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_86cb73ef-339a-48f6-b5d8-363c089ebcce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressCityOrTown_86cb73ef-339a-48f6-b5d8-363c089ebcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_5e20484d-374b-48f9-b096-63d5a5c6f647" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressCountry_5e20484d-374b-48f9-b096-63d5a5c6f647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_65af35c8-f8ac-494d-afcd-9709ddbe1566" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityAddressPostalZipCode_65af35c8-f8ac-494d-afcd-9709ddbe1566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ec7a2973-aedd-419c-973e-92288de44695" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_CityAreaCode_ec7a2973-aedd-419c-973e-92288de44695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6d837b84-9d33-4d22-93bb-beeff9dfc976" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_LocalPhoneNumber_6d837b84-9d33-4d22-93bb-beeff9dfc976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b1bef93c-60c3-47d7-a2ec-c874b50a2f48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_WrittenCommunications_b1bef93c-60c3-47d7-a2ec-c874b50a2f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a45a38cb-01ca-48f2-a77d-3665fd895a89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_SolicitingMaterial_a45a38cb-01ca-48f2-a77d-3665fd895a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_777862d7-a15b-40e2-aa9c-effe11f747f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_PreCommencementTenderOffer_777862d7-a15b-40e2-aa9c-effe11f747f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e2941cce-479e-4014-91c5-b2dc3896240f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e2941cce-479e-4014-91c5-b2dc3896240f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_856e1890-2583-42e0-bbb6-92334808647c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_Security12bTitle_856e1890-2583-42e0-bbb6-92334808647c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_718e1a4a-6d7c-4bd5-b2ab-8d3e9bc0aa7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_TradingSymbol_718e1a4a-6d7c-4bd5-b2ab-8d3e9bc0aa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9c49ff29-666c-47fb-9189-b9889bdbb9f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_SecurityExchangeName_9c49ff29-666c-47fb-9189-b9889bdbb9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_93ef486b-bbf6-4805-a077-43adcf85f0ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityEmergingGrowthCompany_93ef486b-bbf6-4805-a077-43adcf85f0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b520307f-5330-4b9a-bb96-b3e5048e1f05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_AmendmentFlag_b520307f-5330-4b9a-bb96-b3e5048e1f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_12336222-1449-48b3-91ba-1ede111f08c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_e4a0c797-7df5-4b83-8743-80d7b2c5b495" xlink:to="loc_dei_EntityCentralIndexKey_12336222-1449-48b3-91ba-1ede111f08c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>zailablogoa.jpg
<TEXT>
begin 644 zailablogoa.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $II;F<@66%N
M9P  !9 #  (    4   0HI $  (    4   0MI*1  (    #-C@  )*2  (
M   #-C@  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
MM1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!
M"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ
M_]H # ,!  (1 Q$ /P#Z1HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHKB/B?XUD\):%''IY U"])2)B,^6H^\^/Q 'U]JF4E%79K1HSK
M5%3ANSK;O4["P(%]>V]N3T$LJKG\S4MO=6]W%YEK/'.G]Z-PP_,5\AW5U/?7
M+W%[-)<3.<M)*Q9B?J:T/#_B/4_#.HI>:3<M$5/SQY^20>C#O7,L3KL?0RR%
MJ'NSU]-#ZQHK,\.:Y!XC\/6FJVPVI<1Y*9^XW0K^!S6G74G=7/FY1<).,MT%
M%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O$?CS;S#6=)N2
M#Y+0/&#VW!LG]"*]NK$\6>%K/Q=H4FG7V4.=\,RCYHG'0C^H]*SJ1<HV1VX#
M$1P^(C4EL?*E%=IJWPI\5Z9<LD6GF_BS\LULP8,/H>16IX7^#>M:C>1R>($_
MLZR4Y=2P,L@] !T^IK@5.;=K'VDL=AHPY^=6_KH>B?!VWE@^'-L9@0)9I)$S
M_=+<?R-=U4-I:PV-G#:VD:Q00H$C1>BJ!@"IJ]&*Y8I'PE>I[6K*IW=PHHHJ
MC$**** "BBB@ HHHH **** "BBB@!';9&S==H)KR+X=_$?6_$7CF33]3>)[6
MXCD>-%C"^5MY&#WXXYKUN;_CWD_W3_*OG;X/?\E+M/\ KC-_Z#6%234XI'KX
M&C3GAZ\I*[2T_$^C****W/("BBB@ HHHH **** "D9@BEF("J,DGL*6J^H_\
M@NZ_ZXO_ .@F@:5W8H?\)9X>_P"@W8?^!*_XT?\ "6>'O^@W8?\ @2O^-?)Z
M@;1QVI<#TKB^LOL?5?V#3_G?W'U?_P )9X>_Z#=A_P"!*_XT?\)9X>_Z#=A_
MX$K_ (U\H8'I1@>E'UE]@_L&G_._N/J__A+/#W_0;L/_  )7_&C_ (2SP]_T
M&[#_ ,"5_P :^4,#THP/2CZR^P?V#3_G?W'UC'XHT&618XM9L7=R%55N%)8G
MH ,UJUX/\&/"0U/6GUV\CS;6)VP CAY?7_@(_4BO>*Z:<G*-V>%CL/3P]7V<
M)7MN%'2N6\9>/M+\'6V+@_:+YUS%:1GYC[L?X1[UX5XE^(7B#Q/(ZW=XUO:D
M\6MN2B >_=OQJ9UHPT-<)EE;%+FVCW?Z'T%J7C7PWI+E+_6;2-QU02;F'X#-
M9!^+7@P/M_M4_46\F/\ T&OFRBN=XB71'N1R*@E[TF_N/J;3_'?AC5'"6>MV
MC.>B.^P_DV*Z $, 0<@]"*^.:Z/PWX[U[PO*O]GWK/;@_-:SDO&1].WX8JXX
MC^9'-6R*RO1E\G_F?2M]K>EZ;,L6H:A;6LC+N"32A21ZX-5O^$L\/?\ 0;L/
M_ E?\:^>_B!XM@\9ZG8ZA#;O;R1VHBFC;D!@S'@]QS7*8'I1+$6>B"CD:E33
MJ2:?8^N['5+#5%=M.O(+I8SAS#('VGWQ4]Q<0VMN\]S*D448R[N<!1ZDUY1\
M!/\ D&:U_P!=X_\ T$UW'Q!_Y)[K7_7JU;QG>',>/7PRI8KV">ETOO+G_"6>
M'O\ H-V'_@2O^-.3Q3H,LBQQZS8L[$*JK<*22>W6OD[ ]*T-  _X233>/^7N
M+_T,5SK$-O8]N61TXQ;YW]Q];5FS>(]'M]:CTF?4;=+^7&RW9_F.>E:5?-7B
M69O^%RW,FXY754 .>F&45O4GR)'C8'"+%2DF[65SZ5HHHK4\\**** "BB@YV
MG'![&@ R/6C(]:^==6^'GCJ?6+J66TGNF>5F\X7 (<$\$9/Z53_X5QXW_P"@
M7<_]_E_^*KG]M+^4]R.64&K^WC^'^9]+9'K29'J*^:?^%<^-O^@5=?\ ?Y?\
M:3_A7/C7_H$W/_?U?\:7MI?RE?V70_Y_K\/\SZ7R/44M?,Q^'?C5>?[(N_PE
M'^-2:7XK\6> M66&\-TJK@R6-X25=?;/3ZBCV]OB5@>4*2_<U5)]OZ;/I*;_
M (]Y/]T_RKYU^#__ "4RS_ZXS?\ H)KWO2M7MM>\.PZG8DF&YA+J#U4]P?<'
M(KP3X/\ _)3+/_KC-_Z :*NLX!E\7'#8B+W2_P SZ(ENK>W($\\<1/0.X&?S
MJ/\ M*Q'6]M_^_J_XUXKXZ^&_BS5?&5_J%G;B]M[B3=$_GJ"JXX7!/&.E<]_
MPJ?QD?\ F$C_ ,"(_P#&FZLT[<I%/+\-."DZZ3?I_F?17]IV'_/[;_\ ?U?\
M:7^T[#_G]M_^_J_XU\Z_\*E\9?\ 0*7_ ,"(_P#&D_X5/XR_Z!(_\"$_QI>U
MG_*:?V;A?^@A?A_F?1\5W;SMMAN(I#Z(X-2U\P:AX"\6:#;M?7.FSPQP_,TT
M,@;9[_*<CZUZ1\(_']YJ]PV@ZW,9YUC+VT[_ 'G ZJQ[D#D'ZU4:UWRR5C#$
M99R4G5HS4TM_ZU/5Z***W/'"J]^I?3;E5!9C$P  ZG!JQ10-.SN?)P\*^(=H
M_P")%J73_GT?_"E_X17Q#_T M2_\!'_PKZPHKE^K+N?0_P!O5/Y$?)__  BO
MB'_H!:E_X"/_ (53O=-OM,=$U&SN+1G&56>(H6'J,U]<SSQVUO)/.X2*-2[L
MW10.2:^6O&?B23Q5XIN=18D0Y\NW0_PQCI^?7\:RJTHP6YZ67YA5QDVG%)+J
M8-6M-T^XU;4[>PLDWSW$@C0>Y[_3O56O9?@GX3VI+XEO(^6S#: CM_$_]/SK
M*G#GE8[\9B5AJ+J/Y>IZ=X=T.W\.:!:Z7:#Y($P6QR[=68_4UD>/_&</@[03
M,NV2^N,I:Q'N>['V'_UJZHD $G@#K7R]X^\2OXH\775V')MHF\FV7L$4]?Q.
M3^-=U6?LXV1\EEV%>,Q#E4U2U?F85]?7.I7TMY?S-/<3-NDD<\DU7HKOOAM\
M.F\63F_U/?%I4+8.WAIV'\(/8#N?PK@C%R=D?8UJU/#T^>>B1R&E:'JFN3&+
M2+">[<=?*0D+]3T'XUU,7P@\8R1AS8PIG^%[E<U]"V&GVFEV:6FG6T=M!&,+
M'&N *LUUK#QMJSYFKGE5R_=Q27GJ?+6K^ _$VAQM+J&DS")?O2Q8D4?4KG%<
M]7V-UKS/XA_"RUU>VEU/P] MOJ* L\"#"7'X=F]^]1/#V5XG5A,Z4Y*%=6\U
ML>"T4K*R,5<%64X((P0:2N4^C/:_@)_R#-:_Z[Q_^@FNX^('_)/=:_Z]6KA_
M@)_R#-:_Z[Q_^@FNX^('_)/=:_Z]6KT*?\(^)QG_ ",OFOT/ERM#0/\ D9--
M_P"ON+_T,5GUH:!_R,FF_P#7W%_Z&*X%N?95/@?H?6U?,GB,Y^+=X?\ J+#_
M -&"OINOF3Q%_P E:O/^PL/_ $8*[<1LCY/)?CJ>A]-T445TG@A1110 445F
M^(-<M/#FAW.J7Y/E0+G:.KMV4>Y-#=M2HQ<I*,=V:5%?-NL_$SQ7X@OF%G=S
M6<3']W;60(('N1RQJE_:OC@_\O6N?^1*YOK"Z(]R.2U;>_-)GT_17S!_:?CD
M]+C7?REH.I^.1UN-=_*6CZPNP_[%E_S\1]/UY9\=K2)_#>G7A0>='=^6&QSM
M922/_'17FB:IXZ,BB.YUTN3\H ER3^5=_P#$YM1;X1Z&=:!%^;B+S]PP=WEO
MU]Z)5%.#T'1P,L)B:4N=.[Z&Q\&)FD^',RL<B*ZE51Z#:I_F37G/P@.?B9:'
M_IE-_P"@FN_^"A_XH&^_Z^Y/_0%KS_X/?\E*LO\ KC+_ .@5'\AU)6>,_KHS
MZ.HHHKL/E0HHHH ;)&DT3QR*&1U*LI[@]17S7\.,V_Q3TU$. )Y$X]-K"OI:
MOFGP#_R5?3_^ON3^35S5OBB>]E?\"NO+]&?2U%%%=)X(4444 %%%5M1O[?2]
M-N+Z\<1P6\9D=CV % TFW9'F_P :?%?]GZ/'H-I)BXOANGP>5B!Z?\"/Z UX
M56GXBURX\1^(+O5+K(:=\JN?N+T5?P%9E>94GSRN??X'"K#4%#KU]36\,Z#<
M>)O$5KI=KD&9OG<#[B#EF_ 5]46%C;Z9I\%E9QB."WC$<:CL *\]^#?A/^R=
M!;6KR/%WJ 'E@CE(>WYGGZ8KTJNRA#EC=]3YC-\7[>M[./PQ_/J<_P".]2;2
M? FK7<9VR"W9$/NWRC^=?+(KZ.^,)(^&M[CO+$#]-XKYQK#$/WDCULCBE0E+
MN_T18L+.74=1MK* 9EN)5B3ZL<?UKZQT?2[?1='M=.LU"PVT81??U/U)YKYK
M^':H_P 1M$$G3[3GGU"DC]<5]0UIAEHV<F?5'SPI]+7"BBBNH^;"BBB@#YZ^
M,7A^/1_&(O+9 L&I)YI ' D!PWY\'\37GU>U?'M5_LW16_C\Z09]MHKQ6O-K
M*TV?>Y94=3"0<O3[CVOX"?\ (,UK_KO'_P"@FNX^('_)/=:_Z]6KA_@)_P @
MS6O^N\?_ *":[CX@?\D]UK_KU:NNG_"/FL9_R,OFOT/ERM#0/^1DTW_K[B_]
M#%9]:&@?\C)IO_7W%_Z&*X%N?95/@?H?6U?,OBHK!\6KYG.%74U8D]AN!KZ:
MKP?XP^#[NS\02Z_:0-+978!F9!GRI ,<^@.!S7=73<;H^0R:I&-=PD[<RL>\
M Y&1THKY[T?XS>(M+L(K6:*UOUB4*LDP(? Z9(//UK0_X7OK?_0)T_\ [Z?_
M !I^W@1+)L6G9)/YGNE%>%_\+WUO_H$Z?_WT_P#C1_PO?6_^@3I__?3_ .-'
MMX"_L?%_R_BCW2O+?CO/(GAK385)$<EV2_OA#C^=<_%\>-7$JF?1[)H\_,$=
MPQ'MFO1/'7AUO&O@CR[0;;H!;FV#\?-C[I],@D42DJD&HA2P]3 XFG.NK*YA
M_!+3K.+P=)?QQH;N:X=9),?, N,+[#O^->E5\P^'?%VO^ =0N+>!-F6Q/9W2
M'&X=\=0?<5U8^/&L=](L?^^W_P :BG6A&*3.O&99B:M>52&J?F>YT5X;_P +
MXU?_ * ]C_WV]'_"^-7_ .@/9?\ ?QZT]O#N<?\ 8^,_E_%'N5>9?'60#P?8
MH3\S7RD#UPC?XUS7_"^-7[:/9?\ ?QZY76_$?B'XCZS;6[0^;(I*P6MLAVIG
MJ3_B:SJ5HRC9'9@LLKT:\:M6R2UW/4_@JF/AY<G'WKR7_P! 6O.?A/(MM\3K
M)9#C*RQC/KM/^%>Y>#?#P\+^%+/2RP>6-2TS#HSL<M_A^%>'>/?"^I>"_%SZ
MG8"2.TDG^T6MU&.(V)SM)[$'\Q2G%QC%]C3"U:>(K5Z:?Q[?B?1U%>"6OQR\
M0PP*EQ96%RX',A5E)_ '%3_\+WUO_H$Z?_WT_P#C6GMX' \GQ:>R^\]THKPO
M_A>^M_\ 0)T__OI_\:/^%[ZW_P! G3_^^G_QH]O /['Q?\OXH]T) !). .IK
MYH^'A\WXJ:<R\@W,C?HU:6L_&7Q#JNG2VD4-K8K*I1Y(0Q;!ZX)/%:?P7\)W
M4VM_\)#=0M':6Z,MNSC'FNPP2/8 GGU-9RFJDXJ)Z%##3P.%JRK:<RLOQ_S/
M<J***ZSY@**** "O'OC;XKPD/ANSDY;$UW@]OX$_K^5>H:_K-OX?T&[U2\.(
M[>,MC^\W91[DX%?*NJ:E<:OJMSJ%Z^^>YD,CGZ]OH.E<U>=ERKJ>[DV%]K5]
MM+:/Y_\  *E=-X!\+-XL\5P6CJ?LD7[VZ;T0=OQ/%<U7TE\,/"?_  C'A5&N
M4VW][B:?(Y48^5/P'ZDUSTH<\CWLRQ?U:@VOB>B_S.Q1%BC6.-0J* JJ!@ #
MM3J**]$^$.8^(^GMJ7P]U:%%W.L/FJ/]PAOZ5\P5]B21I-$\<BAD=2K ]P:^
M5/%>@R^&O$]YIDH.V)\Q,?XHSRI_+^5<>(CM(^HR*LK2I/U*>CZB^D:W9:C'
MRUK.DN/7!R1^5?6=G=0WUE#=VSAX9T$B,.X(R*^/Z]7^%7Q'BTJ-- UZ;9:E
MO]%N'/$1)^XWH,]#VJ:%11=F=.<8.5:"J05W'\CV^BD5@ZAD(96&00<@BEKN
M/C@HHKC_ !YX_LO"&GO'$Z3ZI(O[FW!SM_VF]!_.E*2BKLUI4IUIJ$%=L\U^
M-VMI?>*+;3('W+81$R8/21^<?@ /SKS.IKJYFO;N6ZNI&EGF<O([=68\DU#7
MF3ES2;/T'#45AZ,:2Z'M?P$_Y!FM?]=X_P#T$UW'Q _Y)[K7_7JU</\  3_D
M&:U_UWC_ /037<?$#_DGNM?]>K5VT_X1\CC/^1E\U^A\N5H:!_R,FF_]?<7_
M *&*SZT- _Y&33?^ON+_ -#%<"W/LJGP/T/K:D95=2K@,I&"",@TM%>L?FIA
M7'@CPQ=2F2?0;!G/5O(49_*HO^%?^$_^@!8_]^JZ*BIY8]C95ZRVD_O9SO\
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M_"G/!W_/E<?^!3_XT44G"+=VBHXO$0CRQFTO4W_#?A'2?"<-Q'HL,D2W#!I
M\K/D@8'6M'4].M]7TNXT^^4O;W"%)%5BI(/N***JR2L92J3E/G;U[G'_ /"G
M/!W_ #Y7'_@4_P#C4EM\)/"5I=17$-G.)(7#H3<N<$'([T45/LX=C=XW$M6=
M1_>SMJ***LY HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140010535966576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  06,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ZAI LAB LIMITED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1144595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4560 Jinke Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bldg. 1, Fourth Floor, Pudong<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Shanghai<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">201210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">86 21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6163 2588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001704292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dei_AdrMember', window );">ADR</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZLAB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value $0.000006 per share*<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">9688<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dei_AdrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dei_AdrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>zlab-20230606_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zlab-20230606.xsd" xlink:type="simple"/>
    <context id="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2023-06-06</startDate>
            <endDate>2023-06-06</endDate>
        </period>
    </context>
    <context id="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-06</startDate>
            <endDate>2023-06-06</endDate>
        </period>
    </context>
    <context id="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-06</startDate>
            <endDate>2023-06-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV80L2ZyYWc6MWE0YzBjYTVkYWU1NGVkMThiMzBjYTVlYTUxOGNhYmQvdGFibGU6YjMzMjlhODkzNzRhNGQzOGI3YWEyZTllYzVjYTdhNmEvdGFibGVyYW5nZTpiMzMyOWE4OTM3NGE0ZDM4YjdhYTJlOWVjNWNhN2E2YV8wLTEtMS0xLTU4MTEw_7aae56b2-7d39-4845-bdfa-89945fe3e6bf">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV80L2ZyYWc6MWE0YzBjYTVkYWU1NGVkMThiMzBjYTVlYTUxOGNhYmQvdGFibGU6YjMzMjlhODkzNzRhNGQzOGI3YWEyZTllYzVjYTdhNmEvdGFibGVyYW5nZTpiMzMyOWE4OTM3NGE0ZDM4YjdhYTJlOWVjNWNhN2E2YV8xLTEtMS0xLTU4MTEw_0c7c2fd8-28cb-4afb-9024-7841b2259332">0001704292</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA1_87f7fa7e-529f-4756-8797-800051bdd6e7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8yNzQ_f591d6cf-dec9-48ea-9a86-21de2325ee84">2023-06-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA3_6046de8d-5433-45f5-a980-d315da838e30">ZAI LAB LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTAtMS0xLTU4MTEw_7fd98739-9bde-48ab-8789-081a2f9930aa">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTEtMS0xLTU4MTEw_1585dd39-3c93-48a1-bf8a-ac92e05e75b5">001-38205</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6MThjZjBkZjk5MzJkNDc5NmIzODYxNzJmYTdhNTkwOTQvdGFibGVyYW5nZToxOGNmMGRmOTkzMmQ0Nzk2YjM4NjE3MmZhN2E1OTA5NF8wLTItMS0xLTU4MTEw_4bcfc59c-e473-4709-8df4-713689fbde3f">98-1144595</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfNQ_d8a290d1-c4d1-4eb8-a6e5-d11d1181982a">4560 Jinke Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfOA_673a6c74-af97-419b-82b1-33b34db36474">Bldg. 1, Fourth Floor, Pudong</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfMTE_ed8e8dab-5814-449a-bfb7-6390b679cfc6">Shanghai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTAtMS0xLTU4MTEwL3RleHRyZWdpb246OWI1ODc5ZWZlN2JmNDBkZTk4YjBlYTBjYWVlNTEwNjZfMTU_b76fec1e-01f7-4355-9fdf-40e4150562b5">CN</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6ZGU3MDI2NzQ3OWVlNGZjOGE0ODJhODI5OTk3MjEzNWUvdGFibGVyYW5nZTpkZTcwMjY3NDc5ZWU0ZmM4YTQ4MmE4Mjk5OTcyMTM1ZV8wLTEtMS0xLTU4MTEw_35cc901b-9a69-4c7a-ba27-df99d5cbfc28">201210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA4_07d9ae4e-057d-4157-a7b8-bb1762d56b72">86 21</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjAz_9b169139-78cb-4ff2-884a-cbf445da0e2d">6163 2588</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M18wLTAtMS0xLTU4MTEw_c8beacb1-fbdc-4548-bec2-0de820c8bf6e">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M18yLTAtMS0xLTU4MTEw_253e6644-daa1-4665-b5e4-eb13da9a9819">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M180LTAtMS0xLTU4MTEw_631199fb-9f39-4acf-8cfb-123879757600">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6NzM1YzIwNTNlOGQ1NDhlNDk3M2Y3NjNhMjA0ZmI5OTMvdGFibGVyYW5nZTo3MzVjMjA1M2U4ZDU0OGU0OTczZjc2M2EyMDRmYjk5M182LTAtMS0xLTU4MTEw_eea57229-57fe-4a7d-8df4-f7185095b3c7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTAtMS0xLTU4MTEw_2ffe3d66-2203-4517-8a9f-2005b51a2660">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTItMS0xLTU4MTEw_c72cb60a-9d09-444b-88db-0825dea37cae">ZLAB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i381bf7a841994185bee62e4aa2f83b50_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8xLTQtMS0xLTU4MTEw_774cfbfc-7c76-4885-ae28-ac065415770b">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8yLTAtMS0xLTU4MTEw_5e6e7d91-c1f0-4661-8cd0-a31335057e41">Ordinary Shares, par value $0.000006 per share*</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i450560421fbb4f4f8af79f315e2226d0_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGFibGU6OGU4NjUwODcwZDIwNGZiNzk4ZDA3ZDNjMWY2NGU2OWIvdGFibGVyYW5nZTo4ZTg2NTA4NzBkMjA0ZmI3OThkMDdkM2MxZjY0ZTY5Yl8yLTItMS0xLTU4MTEw_ee5788a5-175c-44d7-ba61-1f47834a9ea4">9688</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MTVjMmQ1YmI2ZTQyODRhZjg3Mzc2NmNmZjRlMjUxL3NlYzo5NTE1YzJkNWJiNmU0Mjg0YWY4NzM3NjZjZmY0ZTI1MV8xL2ZyYWc6YTY3N2JiZjFiN2ZmNGIyYTkyYTNmYjBlYWExNmM3OTUvdGV4dHJlZ2lvbjphNjc3YmJmMWI3ZmY0YjJhOTJhM2ZiMGVhYTE2Yzc5NV8xNjA0_23edabd0-de73-4a8c-bf23-48142e855e50">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&KTYOML4K$KS([.YLE8E^>6*,]A,N KP?*&4?2NX4[C=(>K@7U!+ P04
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  30<96!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( !-!QE:B'7O$[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( !-!QE:97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M$T'&5JL)0F/D!   4!4  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( !-!QE:?H!OPL0(  .(,   -
M          "  2<-  !X;"]S='EL97,N>&UL4$L! A0#%     @ $T'&5I>*
MNQS     $P(   L              ( ! Q   %]R96QS+RYR96QS4$L! A0#
M%     @ $T'&5JK$(A8S 0  (@(   \              ( ![!   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( !-!QE8D'INBK0   /@!   :
M      "  4P2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( !-!QE9ED'F2&0$  ,\#   3              "  3$3  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  'L4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zlab-20230606.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="zlab-20230606.htm">zlab-20230606.htm</File>
    <File>a2023-06x06xlunarclinicalt.htm</File>
    <File>zlab-20230606.xsd</File>
    <File>zlab-20230606_def.xml</File>
    <File>zlab-20230606_lab.xml</File>
    <File>zlab-20230606_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zlab-20230606.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "zlab-20230606_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zlab-20230606.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zlab-20230606_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zlab-20230606_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "zlab-20230606.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "zlab",
   "nsuri": "http://zailab.com/20230606",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zlab-20230606.htm",
      "contextRef": "ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://zailab.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zlab-20230606.htm",
      "contextRef": "ieda1f9c0ca694a318e0fa43b3adac67a_D20230606-20230606",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AdrMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Receipt (or American Depositary Share, ADS).",
        "label": "ADR [Member]",
        "terseLabel": "ADR"
       }
      }
     },
     "localname": "AdrMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://zailab.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-23-021025-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-021025-xbrl.zip
M4$L#!!0    ( !-!QE:Y]?.L61\  #RA   >    83(P,C,M,#9X,#9X;'5N
M87)C;&EN:6-A;'0N:'1M[3U95]M(NN_W5]20DQXX8QLO8+9TGT,#Z>0."=Q
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ME96DF<^*< QW!2C,/9/%$C8_:M#-H(03J?U<VNOH5H%P'TEDJVOB!RG.E0S
MFFB=HC&!3P*SV4.Y@P!&,D ]8UC/@&I W?111\E83UQ$X"UPC$ZSE)3G&>C.
MF?@UT@ALG3(=@JD"R@NP0*)"P5^\O*^!?'$S]F#78Q-+#_#\SCXWUV^7L0'D
MADY>G"H09+E&?:-".!)=AZO.W0Q;GMO6%0@ $^#==#E ']<^3L%\2F5+E(!?
MUI\55X01\$C/HZ8EOY3O 1@+C>6GEG@K %1CV 5X.4#Y ] F8XU:'X (T"<H
MD7%D4C2@9, (T,C0D;F5)!@*101+!1,!!#TK[ZVR&2<$8/N14A12B( -"L.'
MY2V:1$%@IF2SU?RF!C&]R=(E3#]K6:+^X46GW[8_Q;?$QH^A@R6*LLSZ@"Y4
MB9$_ "C?D+UW7L*)I=5 271^X%-KWO+7N5CT 4-C7/YDK"/)#L4*LK.KAD!]
M:$_ #M'*#7,"\C4(D$2QZ8D$%X&B2? V,P1B0\TY [H#GD?C.*>;Z=B4R)-"
MC 7M6)WD"*;I ="E1OL3Y-4(D!4Y\(#5 ?A )  KIND"2>C$S[D6_P*.'3G1
M=Y5%XI\24 N+E<2$%7$G%*/,Q0+Q%YU$W7GDW #WIPP X!\% A5!"/)6)LA*
MK(D0A&) [F^9$IS%!'R6@R/0MW@9';S$<N0>Y+AR_+#V+( Q8L*)-Y8@WP&2
MY&.@TL>H(Y+80 8(:9!5*ITJP(%G0!>D"=O[UAJ1(T6V0G_'BMA-L(5&JB&Z
MW>9^?XN-IO[N2Q!5@>*_#OHOD31SP)+Q$XFSDXM?Q$3%2+KX7')\,E*P[6:G
M9&S1#E44@]1"$P) IS$<#RAX#]L;.^],;/;:+[<:XB/H5Q7#^EEL)LI]>B;G
M/R4^PR_$<:+A_H.78!E= .3P9(48X.A_A54J=M;CW08$X&[OI3-A=[HO5RR_
MW /(;=,=<@$PZ@#D=@,7QJI^"# S@AE*@2]YCIJI'L$3@QD_'G2,7Q:P#8[W
MD1@$+NOLYZ??^P\/WP'/DPP(H"DGOC1P_A!V47)Y+U^#S_NED;A3.!L.EX69
M_FB?KK7^FO2BQ,>%$]00^P<OB:\1-6#J IA)V  O%R9$R2GJ=:HBH>1/X2H#
ME#X5D %NR4W<W5]Z(U 5JI_"ZV'Q1<_KWG<7+L[7 S&1>TA21TZ(@'TB'+(X
M6;'E2J#;[NR5XZF@%OW,2Q=X":S5+T^;YQU@A8FE4N%C[):>Y:%\\UB1P=^L
M@.$1(X5F]V0,($1-"PR'H9M8\39S<$G?3.#FE@V=@;$^@=/@(ZX\L(W=@6XY
M7ZSH1)W=3@&446 &%%?:W-VULG&!;I!>;)+$GI74 \ +G@[7+/6U>2W6HQ(X
M$I.5BS?9$/T>$](<H(#=NT>=EV"A B3&@NQD1@:M#(\,FE,3@]1!D+8>!FF*
MD.SWJM2QV3_ O_=[^4=;%?7S:^NJ9770_4 :@CM80&HI?Y>K'3@L8*)#,@_!
M=IFK?W!W67'0+FZ1@\0$X 8NO>7K)^7G! DEY3N+BC/XYS@ND@8CU23+NDGL
M<"B#J9PE&T]0+%+-G3\1T)BFK\A.(JOL@:E^V&Y*3)_33>R#^X%\(">).G2_
M'('G !;^[%!']'"ZZ7/*1PY +^_W$0$I0#;UW8,M;EJ$F^W47_!=K[6[UUOZ
M=;O567[KJF7AR^[R6S][V7ZKW_YV=MMK[1]TOYG=[K8Z_8,'+;M-5,:4!K2<
M3&3TXT9OHT;NE'ILMX" !0A)\$0=P]KOD5D6?6U3EX?=R9WHP+?X?Z^UMU<M
MH<'5YQC#3)XH7<F2XBS7?KF@L*!\AA)5ESBC_V_BZN*DG,UYAM?")/C%":K*
M4NKI&4[WT%4UN?4,KD7@ AB5R*J__PRF^ZCJ]/JW4CKORX&+ZJ"_%W@"$$MD
M5X?CLTTQGT7IM\$#7V?F#+7O!^J)8F.=O6?8/,/F,V"S_PR;9;#I[CS#9BG=
M]+\@;)Y \S\M\-HOG]7]2G7?:>X<K#7S?0W0+)%*ZZW-GA PZTTQ3ZO*OJ2X
M_F^#S7HSU-/"YDN:A]^;FN]U/D?-N[SJ<C#]=PKUI7Y_]VBW_0@J_%[AMY@&
M'R/;GB%7,4%[WSCHGE3V/49O/ .O3GK=9^A]*R+O>S-J.CL+C)IM*M9970KT
M)'6C79MK$91F*>HSN3@<\Z/\Q8K^0[X44_1\:7UJQD/*H)[N['DG]5@FV$,9
MZM16>2[NB,[[I[%8.1L$\%5JQR1(UTK2$!-%#22W6DU5T23VN\GB2 ;EKN/:
MZE0&B1UKZFYBRTV-@)/=*NQWP4T-I*L3E^(R5EA2KE)Q3*6P5$G][GB+S\&%
ME;:$ELHB7QOC4U7D:9R-Q+$?PK.I0-P> "],%%;) C2"(2(0.ZQ;>:<Z]I7$
M>I"E16TN-5H(5RBZJ/\.NTL#P! =A0 ,6W]'^\;"W.,L'9M8?^)=P$%RD&Z^
M.S[&=G9^1MZ8^E[RL*V\C>TR-EC6F]1/M/G^W>7Q5JFARN$Z7VH>3J]/C^\O
M]'Y:BLU;;*8F"WP1Z!O%NY?1C<""5E<8V\ 3Z5C0+EQ'*'+DB+IW;+T]2DX]
MX4[^2@\5462U.^BC#@(M0W%JX,2->7B>W2DOH]ZXD['4V#E2Z@CB[<H@,;4]
MG\8M:K+D3LB >NWP'.5NS'Q4 )P'>0-VG2AND20J2"T.I7\K(R\O^$96*E4/
MS_?[.W:.E1V6@/71H8I\DY7: 1>.*7A0%V(C;R4L/]4O3ZXBKHZ-9-9$S,":
M0:WW<*X# E#%#1SNK'DS1=[!5FH>PR)L;((56803#K #$8#Q4;&LB120]2?7
M!^FVZD!#6(FQHXV>!;"8HG3_(]/>34#=CZ&\6=1?G5>SEQNWZAU;RT'WT.ZM
MIZWZM>1])KTQ]5R5&P51*-_I$+ ,<-K;:3=@*P4D$*:1FL)7OI;8!5AT=:^F
M)FHMK"Q3+""QI<)R ;:(IG*DEE-]B0[GVUT+A)K2- MLHZ9>H8+@D#NH][6*
M9+>)1M&7",_5:!ZDW*-1%2XH!JXD+ 1209QF#5!76>3CH4F8 ,\G)F(( (#5
ML"1M+H9#C00/N[:J*I<[EL8G@:(Y;-BK*^$.[LJPQ%FH-:<&YEI#IDH$QMSD
MU _737'PHNM!S,T('.I##2=E\"VE?FY50<O#@/R"_R<&U!%LRQ&_$(]H.SI:
M"_V4@P*;75DX,^ +V3PG*ZJMKM2&1;Y BITHR0J#J=)O#NBGCH[%(["2BE$%
MDMS'5FHK\I"@V=S98;371]XLVO&<2BAOVME"@UAJ(%O4889EZ< W<$-+\&1
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MEXJ_[?=%I]<7^]W=/=$_V.GAQ9Y;NN7ATAU*G,QQSMP3%V%E(+V;48P,V;2
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MWIED+F5K7TS"/ 0[M--(3L"$MK_PE%0E6[86MR2#S:^?4R4;#)@E)"RFX4G
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M8WRKV#O91#N?]Q&P<Q42KK!K?VA#_LHM]S^0]#%0YORXA=<#-0>I.'$#2.&
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MOBQE _5(B/:(MU "T3N.#GQOK")M[BQD,SS)F^\W $WZI58E\(E?IS F69'
M%VYZDNY,0 4]+V=>!G\!J@Z[*"3DR^\H(F@LCH$ YF8$\)$D"0":SP&M&) "
M+6<4^W3W#MWM??1UP!.KR(>^<<P * 4XW$",>UE(468'9"(!*V9"!V?\0 GB
MBXU_G4D,:-H!SA0I/X<L MB\W*T%G/)R,C+F*AH'YS%DX2-<)N(WMT-"@"W
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M<Q5U9JA)XS2A^6JOVM-RW(U>LMLVM3S8X?.H]+V)MO?>%_JR0/+9Z+@S"%F
M]EB?1*@M+A'(1.QH9Q%KX[I*QOBRS7N;DFN&I>LP5F(%10.&HWYI)<)C;GK_
M\14XSVUJU;R4SN#/H(BCK?\"4$L#!!0    ( !-!QE90#W'5C0(  -P(   1
M    >FQA8BTR,#(S,#8P-BYX<V3554UOVS ,O>=7:#Y/\5?2)$:3 FM18$"V
M 5V+]C;(,NT(M25/DINLOWZ2$B\?-=IYV&'SQ1;U'L5'BO3YQ:8JT1-(Q02?
M>^$P\!!P*C+&B[EW=WN-I][%8C X?X?QPX>;);H2M*F :W0I@6C(T)KI%;K/
M0#VB7(H*W0OYR)X(Q@M'NA3U#\F*E491$,6GNS*)8\C&T8S@B(8Y'ID'$\A2
M3":S<4K&$PB"]'V1D(AFDS \PR2?3O%H!BF>DCS $-)1.IY.LNDH=DXW*E%T
M!15!1AA7R4;-O976=>+[Z_5ZN(Z'0A9^% 2A__!I^=5!O1VV9/SQ"+U)9=GB
M8]]NIT1!"W\N2?H+_DR860ZIJ'PK-#@+SCQ$M)8L;31<"UE=04Z:4L^]AG]O
M2,ER!IE)=@DVG4> @VU-9 'Z,ZE U83"J\<M!@A9_:RJA=2(OR#E1*5.3J-P
M04AMJ9&'MOE:"DJTNP06K0S<J>_D^%!JU5JPM0PW*O/\-R,X*$$XF\W\C<UI
M=P2=)7!X;#]Q&.$X[''LL2/&E2:<0I^SS0JWO+\1P_X^]8NAY?6/P3E30(>%
M>/(S8+]S 4[A]J.CY(1SH1W?6G:VNF8\%UN#,=G DS;Z&\C;%GW1=QU7Q+T2
M(JD4Y1OWR:^EJ$%J!NJP9YV#E81\[MG.Q6W??+.-9")I(2\.."Z!W?8-!<KE
M7DG+U3]JPU6F "5L<_,O"Z\E]!5N*,J,*U?H_UY_!GE?_8;"./L#]99]:_81
MR^;>I3!_7 ]9V]W-QZZA[@[;PEH_K:=]"(O /2'"^]\R1HYU[I]B3[PT"K(O
M?.&^3XNZ(^\@KQ I*6E3]N<=9[&3MC.V:=L-%?]XJFS7!Y/'&;;C;#'X"5!+
M P04    "  30<96;3B_GH (   [/@  %0   'IL86(M,C R,S V,#9?9&5F
M+GAM;-U;VW+;.!)]SU=HM:\+"U<"<,69\CK)EFN222KV5*;V185+PV:%(ETD
M'=OS]=O4Q3?)SD1DLKOR@TQ1(/KT.4V@&P1?_G(]*T9?H6[RJCP8LSTZ'D$9
MJIB79P?CWT_?$C/^Y=6+%R__1L@?__ST;O2Z"I<S*-O140VNA3BZRMOST><(
MS9=1JJO9Z'-5?\F_.D)>S2\ZJBYNZOSLO!UQRL7C7^M](2 J;AWA@24B\8\X
MB)XX;95W2@.E_A]G^XZ'J!G+B$O&$&G!$^,2)<""],KH:*28=UKDY9?][L.[
M!D;H7-G,OQZ,S]OV8G\RN;JZVKOV=;%7U6<33JF8K%J/E\VOU]I?B7EK9JV=
MS'^];=KDFQIBMVSRQ_MW)^$<9H[D9=.Z,MP90/.QO;WP/AHU6?R(39M\OYE?
M_ZX*KIW+\TT71D^VZ+Z153/2G2*,$\'VKILX?O5B-%HPY^I05P5\@C1:'O[^
MZ7@=:5ZVDYC/)LLV$U<4B'C>0WMS 0?C)I]=%+ Z=UY#>A+]RN4.E.K@_+WK
M;=(;TSD"J<.E!X)GH>P"?$",FWKOC_FV+Q(AN<NB'1#Q>M^#XJUF+A^2X+6N
M!T [[XC,8.:A'A+J@W[OX5R!?(SP3Y<7SN^%:C:9 SNJOOX50'_B1:0;1FE&
ML[GEQ87W+**T>9EWH\4[_+J\NK/Q/;;ANH4R0AR/\G@PSH6FAD%&.?546J5-
M"EPGH8VE25$MIHLN.A K&$45'O18=$-8=6L& 4 Q/SN-D$]7<\IQF:IZYI;H
MX;B%63,%Z6C05A,=DR+2&T&,QL'>T*@]#\HCI'7=FE4<-!#VSJJO$[2#XG'>
M'70<\H5RW["^H+:?5Z?8=LII5"X*2V(F<?YBVA"K!?ICF=,>ISD!=! O.FL/
M4=^%Q&&]PK^\([:\9;IY_@>HUU8#D+=0!N&/1U4=H3X8TR%$_ AU7L4W97R-
M2<^4)9>\TT 4%9Y(;0(QGFL2O&0\XT(X$P=1\X'9'9)U>SK7]65]]'U3MGE[
M\PG.\J:M7=G^YF8PM:#0-,?L4G!)))>6.(N)*;4"?18,+!.]Y-UD=0?4[4WF
MNKB\O[C'6,[4%U4]=_*DQ8 [JB[+MKXYJB+"X\XH<)+X#$SG:T:\,8XXIZ)E
MB@.#(;1^%L3.2#\<U>N1(/I'PMN\@-\N.V:FBC-)C?2$"8E^,DC$:^9)DB*F
M9#A5K%]6\=CBSFB\)8GK@LK^@IZZZ^.(;N8I7Y3(2V#!X:2AJ"%>*4%D4!EQ
M47.B@S<4I$I<]9N?GS6_,U(/0>^Z[JJ_[H<QUM TRW^=NVP:18J<!T]\BADF
M$5X0)S&= )UE3#AF,M #:+[!],[HW9?6=:VS'Z$UGXIH*.^2"$.U0S>#(D:J
M#I24+(3DL$;](5KS'=;Z^VA=UUH/IO41'GZH3ZNK<FJRX+7 B44(BY!,PIQ!
M14-$)@(U%GP(&U9MME7ZSO"NZ;PEI>LJF^%47J2&4P6<2B,C$1I3"<1CB:<V
M(YG JE^%+&5RP(%[:77G]-V"S'5Q[6#B?JR:UA7_SB_FF7^F7!(J&)*,"T1:
MQ.=2B,1J:F/TP%26#2?Q ]N[)O3VQ&Y8.>FU--8-*8<UN#D0"-IQ+.>[AW<1
M2P$;NB4Z()9S8R)(F?5<I;UO;0<TW9J\#2KV6@#K'BX6'\^K<E749=$([8TD
M-@I,[C'Y(U9XS/\ 4K(Q!:O[W:N/+>Z FKU(W*!HKU6OSW7>ME >5;/99;DL
MW)JI9QZ2%8%D-" B'35Q' ()Z*!7U/$D32]9-YK= 6W[T[E!X%Z+62=5D0>D
ML3Q[[UJH<U=,G51.&*S2* OSG(X3IS5F 5FF4C16.6-[J;MN<P>D[4GD!EU[
MK6E]K*&+,B@#S!]]=<]@ZP\IX7BBM389[X*,83TF*2 LA],$CB; 6-)2IW[3
MZ].V=T#G@8C=H'>OM:Q'L(Z;YA+J^^  BW&LNP''%XL?E.%\PK H]SP&86S&
M)>VWS/$M!+NG?3^2-T1 KQ6N$PB7.+W<,.Y/\[: J5$9,&,IX0H=E!PH\=YG
MF D*(0TU6+V%?N/X(XL[H' O$C<HVFL=Z[1VW=;)DYN9KXJI9@:8DXYD46-Y
MYF,75LX3$P58'ZASNM\-_,#<#FBY/7T;A.RU5+6*JC?7X=R59[!XEAVD38E;
MDF49 M+)XUAA+/'6&.NC][;G-+S)Z@[(VIO,#>H.L%;U9@;U&8;;O^KJJCW'
M:>+"E3=3*P"3]PR+-9\R3 &I(HYJ3:1P,22C$DU#/%S8:'P'M!Z*V@U[07HM
M5QVBI['S]FWASJ9><2JH3D0)0=$[ZQ"3S8@7H*C$82?1?G?R W,[(.OV]&T0
M<H M6T<(I7;%,29RU[_"S93AY)YQS@F3TF)H>8&CB7>$0<1$'O&8T&]]8Z/9
M'1"V/YT;!.ZU@+7!S5/G,;%3E&EKHR?1&DZD]))X"(S88$3F8S">]WL8^)3E
M 66^]Z;$3]QOV8O*35LN1XL]\/NAJ!J(!^.VOH2[DU79PG7[IIB77 ?C!LZZ
M@VUCXK(A9\Y=3.<;RKJ.C@K7-!_225N%+X?7>3--+@7&E24B87J(PQ$G/D'$
M,4EJ#YX9X9^;LI-K_%RLI:5%=$#1-JLS=V'R33 #QLHS;[!\,W:VD+GZ$70/
MN%]W!>P^GM?S4?,O(9H^>J5FH$!81S/DI/#4^T!W^@\L5_5#N/XY4>!C$HF+
M1+CDW<-O0&0N6:(XUAF2!2_\<_/#_[+Z#]ZN^B^*_ST4#[Q5_S#6[V&Y_U [
MM&R("EA!2&H2,5V:PAGZ9T3T7/7;LWUKZN?E=T-Q7O4E;, 7:&Y]JF:S;C\X
MNK0$A+EDREC$,(PJ$6E]MZCC!(E<9LS'3(KPW/.JK>[4QR#^;[4=AM8G[\Z7
MDT>$8!KZY=6+Y>GNHWN%^-6+_P!02P,$%     @ $T'&5E- ?(:[#   MW<
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M+7^XT:]/%LGL9JK7[UUGVM2'G699)6J!DA4H452@_/NNSDY[P#\0WGP;ZP'
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M.+*R'9AP<O!=*7>R[JU@@WGVKC0VS7IGF[[#\.5QYPD-8R[]P J3"@UV]!T
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MO-&_]%^1?_'D?U!+ 0(4 Q0    ( !-!QE:Y]?.L61\  #RA   >
M      "  0    !A,C R,RTP-G@P-GAL=6YA<F-L:6YI8V%L="YH=&U02P$"
M% ,4    "  30<967$UO?8 7  !$H0  $0              @ &5'P  >FQA
M8BTR,#(S,#8P-BYH=&U02P$"% ,4    "  30<964 ]QU8T"  #<"   $0
M            @ %$-P  >FQA8BTR,#(S,#8P-BYX<V102P$"% ,4    "  3
M0<96;3B_GH (   [/@  %0              @ $ .@  >FQA8BTR,#(S,#8P
M-E]D968N>&UL4$L! A0#%     @ $T'&5E- ?(:[#   MW<  !4
M     ( !LT(  'IL86(M,C R,S V,#9?;&%B+GAM;%!+ 0(4 Q0    ( !-!
MQE9KSXB;&@@  /!    5              "  :%/  !Z;&%B+3(P,C,P-C V
>7W!R92YX;6Q02P4&      8 !@"3 0  [E<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
